Clinical Trial Update: Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating OCS-01 eye drops for postoperative inflammation after cataract surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Ocular Inflammation

Drugs mentioned

• OCS-01 Eye Drops (OCS-01)

Snippet

Sponsor: Oculis | Conditions: Inflammation Eye, Pain, Postoperative | Phase 3 | Status: TERMINATED